Ibuprofen compared with indometacin for patent ductus arteriosus
A Cochrane review reports that ibuprofen is as effective as indometacin for closure of patent ductus arteriosus in preterm or low-birthweight babies, and is associated with a lower risk of necrotising enterocolitis, reduced time on assisted ventilation and a lower risk of negative effects on renal function.
Collaborative care for depression
A cluster randomised controlled trial in English general practices suggests that collaborative care delivered by mental health workers acting as care managers is more effective at reducing depression than usual care.
Venous thromboembolic diseases -Interventions to reduce substance misuse among vulnerable young people
Eyes on Evidence helps contextualise important new evidence, highlighting areas that could signal a change in clinical practice. It does not constitute formal NICE guidance. The commentaries
included are the opinions of contributors and do not necessarily reflect the views of NICE.
When you only have 10 minutes with a patient, where do you start and how do you finish? This BMJ Learning module will look at the key elements of a consultation and ensure nothing of importance is forgotten.
Effectiveness of biofeedback for managing stress incontinence in women
A new study funded by the HTA Programme will find out whether the use of biofeedback can help to improve the results of teaching pelvic floor exercises for women with stress or mixed urinary incontinence. [more…]
SMILE to help those with poorly controlled epilepsy
A new study funded by the HTA Programme will look at how effective a programme called Self-Management education for adults with poorly controlled epilepsy (SMILE) is in helping those with poorly controlled seizures to become ‘experts’ in dealing with their epilepsy. [more…]
Exercise ineffective against depression in care home residents finds HTA research published in The Lancet
Exercise is not effective in reducing rates of depression among elderly care home residents, according to the findings of an HTA Programme study. [more…]
The MHRA have just launched a learning module on selective serotonin reuptake inhibitors (SSRI) antidepressants for clinical practitioners. This self-directed learning package outlines the key risks of this important class of medicines. For each adverse effect, the package outlines:
the main features of the adverse effect
factors that increase the risk
how the risk can be reduced
specific treatment for the adverse effect.
A self-assessment exercise, together with full feedback, complements the learning material. SSRI learning module